中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
21期
75-76
,共2页
曲安奈德%糖尿病%黄斑囊样水肿
麯安奈德%糖尿病%黃斑囊樣水腫
곡안내덕%당뇨병%황반낭양수종
Triamcinolone acetonide%Diabetes%Cystoid macular edema
目的探讨曲安奈德治疗糖尿病黄斑囊样水肿的临床疗效。方法选取2011年8月至2013年1月我院收治的60例糖尿病黄斑囊样水肿患者,共84眼。所有患者行球后注射曲安奈德后测量评价患者治疗1周后视力恢复情况;将治疗后1、2、3个月后的视力、眼底血管造影和黄斑中心凹视网膜厚度与治疗前比较,随访患者并发症发生情况。结果治疗1周后,全部患者视力提高率为92.86%(78/84眼);治疗1、2、3个月后患者眼底血管造影黄斑部荧光渗漏面积明显缩小或消失,视力和黄斑中心凹视网膜厚度均优于治疗前,差异显著,具有统计学意义(P<0.05);所有患者随访3个月期间,并发症发生率为0。结论球后注射曲安奈德治疗糖尿病黄斑囊样水肿具有良好效果,不良反应少的优点,值得在临床推广应用。
目的探討麯安奈德治療糖尿病黃斑囊樣水腫的臨床療效。方法選取2011年8月至2013年1月我院收治的60例糖尿病黃斑囊樣水腫患者,共84眼。所有患者行毬後註射麯安奈德後測量評價患者治療1週後視力恢複情況;將治療後1、2、3箇月後的視力、眼底血管造影和黃斑中心凹視網膜厚度與治療前比較,隨訪患者併髮癥髮生情況。結果治療1週後,全部患者視力提高率為92.86%(78/84眼);治療1、2、3箇月後患者眼底血管造影黃斑部熒光滲漏麵積明顯縮小或消失,視力和黃斑中心凹視網膜厚度均優于治療前,差異顯著,具有統計學意義(P<0.05);所有患者隨訪3箇月期間,併髮癥髮生率為0。結論毬後註射麯安奈德治療糖尿病黃斑囊樣水腫具有良好效果,不良反應少的優點,值得在臨床推廣應用。
목적탐토곡안내덕치료당뇨병황반낭양수종적림상료효。방법선취2011년8월지2013년1월아원수치적60례당뇨병황반낭양수종환자,공84안。소유환자행구후주사곡안내덕후측량평개환자치료1주후시력회복정황;장치료후1、2、3개월후적시력、안저혈관조영화황반중심요시망막후도여치료전비교,수방환자병발증발생정황。결과치료1주후,전부환자시력제고솔위92.86%(78/84안);치료1、2、3개월후환자안저혈관조영황반부형광삼루면적명현축소혹소실,시력화황반중심요시망막후도균우우치료전,차이현저,구유통계학의의(P<0.05);소유환자수방3개월기간,병발증발생솔위0。결론구후주사곡안내덕치료당뇨병황반낭양수종구유량호효과,불량반응소적우점,치득재림상추엄응용。
Objective To investigate the triamcinolone acetonide for diabetic macular edema clinical efficacy. Methods August 2011-2013 in January in our hospital 60 cases of cystoid macular edema in patients with diabetes, a total of 84. All patients underwent retrobulbar injection of triamcinolone acetonide in patients after treatment, measurement and evaluation of visual acuity after 1 week of treatment situations;would 1,2,3 months after treatment visual,acuity macular lfuorescein leakage area and central macular thickness than before treatment, the incidence of complications in patients with follow-up. Results 1 week after treatment, visual acuity improved in all patients was 92.86%(78/84);1,2,3 months after treatment macular lfuorescein leakage area was signiifcantly reduced or disappeared, visual acuity and central macular thickness were better than before treatment, the difference was signiifcant, with statistical signiifcance (P<0.05);All patients were followed three month period, the complication rate was 0. Conclusion Triamcinolone acetonide treatment of diabetic macular edema with better treatment, the advantage of fewer adverse reactions, it is worthy of clinical application.